{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:42:14Z","timestamp":1778035334579,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.rmed.2015.05.014","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T16:27:12Z","timestamp":1432225632000},"page":"931-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Pleural neoplastic pathology"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-935X","authenticated-orcid":false,"given":"Georgia","family":"Karpathiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Stefanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios E.","family":"Froudarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000112221","article-title":"Diagnostic work-up of pleural effusions","volume":"75","author":"Froudarakis","year":"2008","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000334743","article-title":"Pleural diseases in the molecular era \u2013 time for more answers: introduction","volume":"83","author":"Froudarakis","year":"2012","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.rmed.2015.05.014_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0002-9343(77)90154-1","article-title":"Carcinomatous involvement of the pleura: an analysis of 96 patients","volume":"63","author":"Chernow","year":"1977","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1378\/chest.117.1.73","article-title":"Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease","volume":"117","author":"Burrows","year":"2000","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2015.05.014_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1378\/chest.112.2.430","article-title":"Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions","volume":"112","author":"Zimmer","year":"1997","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2015.05.014_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000356764","article-title":"Prognostic factors in patients presenting with pleural effusion revealing malignancy","volume":"87","author":"Anevlavis","year":"2014","journal-title":"Respiration"},{"issue":"6","key":"10.1016\/j.rmed.2015.05.014_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000339259","article-title":"Malignant pleural mesothelioma: from the bench to the bedside","volume":"83","author":"Astoul","year":"2012","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.rmed.2015.05.014_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1440-1843.2011.01957.x","article-title":"Pathology of the pleura: what the pulmonologists need to know","volume":"16","author":"Cagle","year":"2011","journal-title":"Respirology"},{"issue":"12","key":"10.1016\/j.rmed.2015.05.014_bib10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1684\/bdc.2013.1857","article-title":"Malignant pleural mesothelioma: 2013 state of the art","volume":"100","author":"Campbell","year":"2013","journal-title":"Bull Cancer"},{"issue":"6","key":"10.1016\/j.rmed.2015.05.014_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/thoraxjnl-2013-203744","article-title":"Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma","volume":"69","author":"Lacourt","year":"2014","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.rmed.2015.05.014_bib12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.rmed.2015.05.014_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/djs513","article-title":"Pleural plaques and the risk of pleural mesothelioma","volume":"105","author":"Pairon","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.rmed.2015.05.014_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V","article-title":"Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: diagnosis","volume":"72","author":"Boutin","year":"1993","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","article-title":"Molecular changes in mesothelioma with an impact on prognosis and treatment","volume":"136","author":"Jean","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.rmed.2015.05.014_bib16","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1378\/chest.11-3204","article-title":"Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients","volume":"142","author":"Finn","year":"2012","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmed.2015.05.014_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/PAS.0b013e3182910c82","article-title":"Diffuse intrapulmonary malignant mesothelioma masquerading as interstitial lung disease: a distinctive variant of mesothelioma","volume":"37","author":"Larsen","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.rmed.2015.05.014_bib18","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/01.pas.0000165529.78945.dc","article-title":"Localized malignant mesothelioma","volume":"29","author":"Allen","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.rmed.2015.05.014_bib19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/JTO.0b013e318211127a","article-title":"Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma","volume":"6","author":"Kadota","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.rmed.2015.05.014_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/PAS.0b013e31802baad7","article-title":"Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases","volume":"31","author":"Galateau-Salle","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.rmed.2015.05.014_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00000478-200009000-00001","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"24","author":"Churg","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.rmed.2015.05.014_bib22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.5858\/arpa.2012-0112-RA","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"136","author":"Churg","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.rmed.2015.05.014_bib23","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/PAS.0b013e31822a2481","article-title":"The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas","volume":"35","author":"Churg","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/PAS.0b013e31826ab1c0","article-title":"IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations","volume":"37","author":"Lee","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rmed.2015.05.014_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.rmed.2015.05.014_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.rmed.2015.05.014_bib27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/PAS.0b013e31825d5371","article-title":"Utility of a CEA, CD15, calretinin, and CK5\/6 panel for distinguishing between mesotheliomas and pulmonary adenocarcinomas in clinical practice","volume":"36","author":"Mohammad","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/path.1128","article-title":"Molecular cytogenetic differences between histological subtypes of malignant mesotheliomas: DNA cytometry and comparative genomic hybridization of 90 cases","volume":"197","author":"Krismann","year":"2002","journal-title":"J Pathol"},{"issue":"1\u20132","key":"10.1016\/j.rmed.2015.05.014_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000109618","article-title":"Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH","volume":"119","author":"Lindholm","year":"2007","journal-title":"Cytogenet Genome Res"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ijc.23949","article-title":"Genomic events associated with progression of pleural malignant mesothelioma","volume":"124","author":"Ivanov","year":"2009","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cancergencyto.2006.04.011","article-title":"Cytogenetic and molecular genetic changes in malignant mesothelioma","volume":"170","author":"Musti","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1349-7006.2009.01336.x","article-title":"Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells","volume":"101","author":"Sekido","year":"2010","journal-title":"Cancer Sci"},{"issue":"24","key":"10.1016\/j.rmed.2015.05.014_bib33","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","article-title":"High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas","volume":"92","author":"Bianchi","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.rmed.2015.05.014_bib34","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Sekido","year":"1995","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"10.1016\/j.rmed.2015.05.014_bib36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.rmed.2015.05.014_bib37","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.rmed.2015.05.014_bib38","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JTO.0b013e31829e7ef9","article-title":"Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations","volume":"8","author":"Zauderer","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.rmed.2015.05.014_bib39","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/carcin\/bgn059","article-title":"Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma","volume":"29","author":"Christensen","year":"2008","journal-title":"Carcinogenesis"},{"issue":"23","key":"10.1016\/j.rmed.2015.05.014_bib40","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","article-title":"Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ijc.22341","article-title":"Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers","volume":"120","author":"Tomii","year":"2007","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.rmed.2015.05.014_bib43","first-page":"1265","article-title":"The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas","volume":"20","author":"Kimura","year":"2008","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2006.06.017","article-title":"Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma","volume":"54","author":"Fischer","year":"2006","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.rmed.2015.05.014_bib45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/JTO.0b013e3181c5e366","article-title":"Histone deacetylase inhibitors in malignant pleural mesothelioma: preclinical rationale and clinical trials","volume":"5","author":"Paik","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.rmed.2015.05.014_bib46","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1038\/cddis.2013.258","article-title":"SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma","volume":"4","author":"Crawford","year":"2013","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.rmed.2015.05.014_bib47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis","volume":"48","author":"Guled","year":"2009","journal-title":"Genes Chromosom Cancer"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib48","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.rmed.2015.05.014_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","article-title":"Functional inactivation of NF2\/merlin in human mesothelioma","volume":"64","author":"Thurneysen","year":"2009","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.rmed.2015.05.014_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.25555","article-title":"Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma","volume":"117","author":"Varghese","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.6004\/jnccn.2012.0007","article-title":"Novel therapies in phase II and III trials for malignant pleural mesothelioma","volume":"10","author":"Zauderer","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"15","key":"10.1016\/j.rmed.2015.05.014_bib52","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lungcan.2012.06.011","article-title":"Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium","volume":"78","author":"Campbell","year":"2012","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/bjc.2013.368","article-title":"Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma","volume":"109","author":"Ceresoli","year":"2013","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.rmed.2015.05.014_bib55","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/thx.53.11.915","article-title":"Telomerase activity in human pleural mesothelioma","volume":"53","author":"Dhaene","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2015.05.014_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7150\/jca.3965","article-title":"Telomerase-independent paths to immortality in predictable cancer subtypes","volume":"3","author":"Durant","year":"2012","journal-title":"J Cancer"},{"issue":"13","key":"10.1016\/j.rmed.2015.05.014_bib57","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1158\/1078-0432.CCR-08-0099","article-title":"Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma","volume":"14","author":"Villa","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.rmed.2015.05.014_bib58","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/onc.2013.351","article-title":"Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma","volume":"33","author":"Tallet","year":"2014","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.rmed.2015.05.014_bib59","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1309\/AJCPQEG6YNN6CNAL","article-title":"Solitary fibrous tumor: is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma?","volume":"137","author":"Fritchie","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.rmed.2015.05.014_bib60","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0046-8177(95)90147-7","article-title":"Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites","volume":"26","author":"Hanau","year":"1995","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-5223(19)41262-2","article-title":"Localized mesothelioma of the pleura: benign and malignant variants","volume":"75","author":"Okike","year":"1978","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"10.1016\/j.rmed.2015.05.014_bib62","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/PAS.0b013e31817a8a89","volume":"32","author":"Schirosi","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0003-4975(01)03374-4","article-title":"Solitary fibrous tumors of the pleura","volume":"74","author":"de Perrot","year":"2002","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.rmed.2015.05.014_bib64","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00000478-198908000-00003","article-title":"Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases","volume":"13","author":"England","year":"1989","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.rmed.2015.05.014_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/PAS.0b013e31826a92f5","article-title":"Intrapulmonary solitary fibrous tumors: clinicopathologic and immunohistochemical study of 24 cases","volume":"37","author":"Rao","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib66","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000658-194207000-00004","article-title":"Hemangiopericytoma: a vascular tumor featuring Zimmermann's pericytes","volume":"116","author":"Stout","year":"1942","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.rmed.2015.05.014_bib67","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/PAS.0b013e3181a6cd33","article-title":"Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component\u2013is this dedifferentiated SFT?","volume":"33","author":"Mosquera","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.rmed.2015.05.014_bib68","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/PAS.0000000000000137","article-title":"STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors","volume":"38","author":"Yoshida","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.rmed.2015.05.014_bib69","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.rmed.2015.05.014_bib70","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ajpath.2013.12.016","article-title":"Solitary fibrous tumors\/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features","volume":"184","author":"Barthelmess","year":"2013","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.rmed.2015.05.014_bib71","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/cncr.28506","article-title":"Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors","volume":"120","author":"Yamada","year":"2014","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.rmed.2015.05.014_bib72","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.humpath.2010.12.025","article-title":"Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors","volume":"42","author":"Schildhaus","year":"2011","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.rmed.2015.05.014_bib73","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","article-title":"Well-differentiated papillary mesothelioma with invasive foci","volume":"38","author":"Churg","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.rmed.2015.05.014_bib74","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/00000478-199610000-00007","article-title":"Adenomatoid tumors of the pleura","volume":"20","author":"Kaplan","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.rmed.2015.05.014_bib75","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.pas.0000147401.95391.9a","article-title":"Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group","volume":"29","author":"Begueret","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.rmed.2015.05.014_bib76","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00428-011-1160-4","article-title":"TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas","volume":"459","author":"Lino-Silva","year":"2011","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.rmed.2015.05.014_bib77","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000478-200105000-00007","article-title":"Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma","volume":"25","author":"Miettinen","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.rmed.2015.05.014_bib78","first-page":"626","article-title":"Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma","volume":"11","author":"Lasota","year":"1998","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.rmed.2015.05.014_bib79","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/PAS.0000000000000346","article-title":"Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions","volume":"39","author":"Anderson","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.rmed.2015.05.014_bib80","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosom Cancer"},{"issue":"8","key":"10.1016\/j.rmed.2015.05.014_bib81","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosom Cancer"},{"issue":"7","key":"10.1016\/j.rmed.2015.05.014_bib82","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.5858\/2008-132-1149-PPNEOT","article-title":"Primary pleural neoplasia: entities other than diffuse malignant mesothelioma","volume":"132","author":"Guinee","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.rmed.2015.05.014_bib83","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0272-5231(05)70082-4","article-title":"Malignancy metastatic to the pleura","volume":"19","author":"Sahn","year":"1998","journal-title":"Clin Chest Med"},{"issue":"8","key":"10.1016\/j.rmed.2015.05.014_bib84","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours","volume":"2","author":"Goldstraw","year":"2007","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.rmed.2015.05.014_bib85","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000338169","article-title":"Pleural effusion in lung cancer: more questions than answers","volume":"83","author":"Froudarakis","year":"2012","journal-title":"Respiration"},{"issue":"6","key":"10.1016\/j.rmed.2015.05.014_bib86","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2217\/fon.11.45","article-title":"Diagnostic molecular biomarkers for malignant pleural effusions","volume":"7","author":"Sriram","year":"2011","journal-title":"Future Oncol"},{"issue":"4","key":"10.1016\/j.rmed.2015.05.014_bib87","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1378\/chest.125.4.1546","article-title":"Pleural effusions in hematologic malignancies","volume":"125","author":"Alexandrakis","year":"2004","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rmed.2015.05.014_bib88","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.5858\/arpa.2012-0294-RS","article-title":"Primary effusion lymphoma","volume":"137","author":"Patel","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.rmed.2015.05.014_bib89","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pap.0000194627.50878.02","article-title":"Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation","volume":"12","author":"Aozasa","year":"2005","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"10.1016\/j.rmed.2015.05.014_bib90","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000135255","article-title":"Rare cases of primary pleural Hodgkin and non-Hodgkin lymphomas","volume":"77","author":"Steiropoulos","year":"2009","journal-title":"Respiration"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611115001845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611115001845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:33:34Z","timestamp":1760614414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611115001845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":90,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0954611115001845"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2015.05.014","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pleural neoplastic pathology","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2015.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}